Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Predictive Oncology Inc.

< Previous 1 2 Next >
Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Announces 1-for-15 Reverse Stock Split
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers LH POAI
Court Denies Renovaro Motion for an Expedited Trial in July
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI RENB
Predictive Oncology Closes Registered Direct Offering
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Announces Agreement to be Acquired by Renovaro
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI RENB
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
From Predictive Oncology Inc.
Via GlobeNewswire
Tickers POAI
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.